Цеолат

Quick links

Choose a section

Quick links to important sections

Advertisements

Цеолат

Advertisements
Advertisements

Treatment option: Dyspepsia, Flatulence

Advertisements

Overview of Цеолат

What is Цеолат? Identity, Classification, and Origin

Property Description
Active ingredient Dimethicone (Polydimethylsiloxane)
Pharmacological class Miscellaneous topical agent, Antifoaming agent
Common use Skin protection, Relief from bloating/gas
Origin Synthetic (Silicone-based polymer)
Route(s) Cutaneous (topical), Oral

Цеолат is a pharmaceutical preparation whose active substance is Dimethicone, which is chemically defined as Polydimethylsiloxane. This compound is broadly categorized within the pharmacological class of a miscellaneous topical agent and antifoaming agent, reflecting its physical, non-systemic mechanisms of action. The drug entity is characterized by its active substance being a synthetic, inert silicone-based polymer, differentiating its origin from compounds derived from natural sources. Dimethicone is recognized as a suitable skin protectant in Over-the-Counter (OTC) products, underscoring its general suitability for external use. The stability and safety profile of silicone polymers like Dimethicone are established across both external and internal applications.


Composition and Available Forms

The composition of Цеолат is centered on Dimethicone as a single active ingredient product, available in various pharmaceutical preparation forms suited for different routes of administration. These forms include a variety of topical products, such as creams and lotions for cutaneous application, as well as specialized oral forms like liquids or tablets. Dimethicone's high molecular weight and inertness contribute to its low systemic absorption across the skin barrier. This lack of absorption means the substance primarily exerts its effect locally on the surface it is applied to. The substance's inertness is what distinguishes it from its close derivative, Simethicone, a compound that is an activated blend specifically formulated to maximize the internal antifoaming property.


General Purpose: Physical Mechanism and Benefits

The general purpose of Цеолат is to provide relief by leveraging two distinct, physical mechanisms of action. On the skin, it uses barrier formation (occlusive action) to create a protective film that helps reduce moisture loss and maintain the skin’s integrity, aiding in skin protection. Clinically recognized for its dermatological inertness, Dimethicone is frequently recommended for individuals with sensitive skin.

For internal use, the active ingredient employs surface tension reduction, which is an antifoaming effect that causes small, entrapped gas bubbles in the gastrointestinal tract to combine into larger, more easily expelled masses. This physical action generally helps to manage the discomfort associated with bloating and pressure from excess gas, serving as a non-systemic intervention for temporary relief of trapped wind.

Advertisements

What side effects are possible with Цеолат?

Possible Side Effects and Safety Information

The safety profile of Цеолат, whose active ingredient is Dimethicone (Polydimethylsiloxane), is largely defined by its physical, non-systemic mechanism of action and confirmed minimal systemic absorption following both oral and cutaneous use. Regulatory documents classify adverse reactions primarily based on the affected organ system and documented frequency.


Adverse Reaction Classification

System-Organ Class (SOC) Frequency Classification Adverse Reactions (Officially Listed)
Skin and Subcutaneous Tissue Disorders Common Localized irritation, redness, or pruritus (itching) at the site of topical application.
Gastrointestinal Disorders Common to Rare Mild gastrointestinal discomfort or loose stools with oral use. Rarely, intestinal obstruction or bezoar formation is documented with high molecular weight silicone polymers.
Immune System Disorders Rare to Not Known Severe systemic hypersensitivity (allergic reaction) to the active substance or excipients.

Serious Safety Considerations

The most clinically significant, though rare, documented adverse reaction is the potential for severe systemic hypersensitivity. Symptoms of a major allergic reaction may include swelling of the face, tongue, or throat and difficulty breathing. Furthermore, the product is contraindicated in any individual with a known allergy or hypersensitivity to Dimethicone or any other component in the specific formulation.

For topical application, official labeling restricts use on deep or puncture wounds, animal bites, or serious burns. Due to the substance's non-absorbed nature, systemic exposure during pregnancy or lactation is not expected, and no specific safety adjustments are mandated for patients with hepatic or renal impairment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Цеолат (Dimethicone) strictly defines the overdose profile based on the substance's inherent properties as a physiologically inert compound with negligible systemic absorption. Consequently, regulatory documents indicate that systemic toxic effects from overdose are unlikely, and no cases of severe life-threatening outcomes have been formally documented or reported in available regulatory summaries.


Documented Overdose Manifestations and Required Actions

Feature Official Regulatory Statement
Documented Presentations The only documented minor presentation is the theoretical possibility of constipation, reflecting a localized effect within the gastrointestinal (GI) tract.
Severity Classification Systemic effects are classified as unlikely due to the lack of absorption.
Required Emergency Action Seek immediate medical attention or emergency help if excessive amounts are accidentally used or taken.
Immediate Contact Contact a Poison Control Center (e.g., call the Poison Help line) immediately, as mandated by regulators for accidental exposure.

Management and Antidote Information

  • No specific antidote is known for the active substance. Management is typically symptomatic and supportive.
  • For the minor manifestation of constipation, treatment involves administering fluids and maintaining observation.

The regulatory approach emphasizes that immediate help-seeking is a mandated procedural step for excessive exposure, regardless of the drug's low systemic risk profile, which is defined by its negligible absorption.

Advertisements

Therapeutic Uses of Цеолат

What Цеолат treats: main uses and benefits

The main uses of Zeolite (often a specific form like clinoptilolite) are applied across domains where additional symptomatic support is needed. This capacity is considered relevant for easing symptoms related to systemic imbalance or symptoms linked to organ-specific functional stress.

A specific form, PMA-zeolite, is commonly used across conditions presenting with acute episodes in the gastrointestinal tract and is relevant for managing symptoms that interfere with daily comfort within the intestinal system. This supportive relief may assist with coping more steadily with symptom fluctuations, providing support during episodes of heightened discomfort. Relevant uses may include situations involving temporary physiological imbalance and scenarios where additional management of discomfort is required.

“This supportive relief contributes to easing the overall symptom load during symptomatic periods.”

This assistance is relevant for easing discomfort during periods of heightened symptoms and supports a sense of stability when symptoms are more noticeable. It assists patients during difficult episodes by easing distress and is commonly used in clinical settings that involve acute or unstable symptom patterns.


Quick Fact: Relief for Symptoms that interfere with daily functioning

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Цеолат? (Dimethicone)

Population eligibility for Цеолат (Dimethicone) is broadly defined by regulatory bodies due to the active substance's non-systemic, physical mechanism of action. Official regulatory labeling establishes clear rules regarding who is permitted to use the medicine and who is prohibited.


Populations Permitted for Use

The medicine is authorized for use across nearly all demographics. Use is established and permitted for infants, children, and adults, with oral forms used from birth onwards. It is also permitted for use during pregnancy and lactation as the ingredient is not systemically absorbed.

Absolute Contraindications and Restrictions

The only absolute prohibition for use is a known hypersensitivity to Dimethicone or any other component in the formulation. Because the substance is not absorbed, regulatory documents document no restrictions based on systemic conditions like hepatic or renal impairment.

For topical application, use is conditionally restricted and must not be applied over deep puncture wounds, infections, or severe lacerations, as defined by regulatory standards for skin protectants.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Цеолат (active ingredient: Dimethicone, or Polydimethylsiloxane) is a pharmacologically inert substance with minimal to absent systemic absorption. This characteristic is the primary factor defining its interaction profile in regulatory documentation.

Official government regulatory information confirms the absence of systemic drug interactions typically associated with absorbed medications, as Dimethicone is not metabolized by liver enzymes (e.g., CYP pathways) and does not engage in drug transporter-mediated interactions (e.g., P-gp).

The established interaction profile focuses instead on potential physical adsorption when the product is administered orally, which may alter the concentration of co-administered oral medications. This effect is documented by the U.S. FDA prescribing information for specific drugs, such as the oral contraceptive component Segesterone acetate, which may experience altered serum concentrations when co-administered with Dimethicone.

No formal contraindications based on interaction risk are listed in official labels. Furthermore, no specific interactions with food, alcohol, or herbal products are explicitly documented in regulatory monographs for the single-ingredient product.

Advertisements

Mechanism of Action

How Цеолат Works

The action of Цеолат (Dimethicone) is defined by its highly localized physical mechanism, which is non-systemic and does not require interaction with biological targets like receptors and enzymes. Instead, it engages in two distinct forms of interface modulation at the site of application.


Effect on Intraluminal Gas Dynamics

This domain covers the action of the polymer within the gastrointestinal tract, targeting the surface tension of digestive fluids. By acting as an antifoaming agent, Dimethicone physically reduces this tension, which destabilizes small, trapped gas bubbles and promotes their coalescence into larger, free gas masses. This physical adjustment facilitates the efficient mobilization and expulsion of gas, influencing the physical dynamics of gas concentration within the lumen.


Impact on Epidermal Barrier Function

For topical application, the mechanism focuses on creating an inert, occlusive physical barrier on the skin's surface, the stratum corneum. The compound's hydrophobic nature allows it to form a non-absorbable film that physically impedes the passage of water vapor. This action modulates transepidermal water loss (TEWL), which affects the hydration and structural integrity of the skin barrier.

Advertisements

Dosage and Administration Information

How to Use Цеолат: Official Administration Guidelines

Цеолат is administered via two distinct official routes: topically (cutaneous) for skin applications and orally for its antifoaming effect. This dual administration approach determines the appropriate pharmaceutical form to be used.


Dosing and Frequency

Usage is structured by specific labeled doses and a maximum daily limit. For oral administration in adults, a typical single dose ranges from 60 mg to 125 mg. Intake is permitted up to four times a day, though the total daily dose must not exceed 500 mg within a 24-hour period. Topical administration is typically applied two to three times daily, or as needed, as a thin film to the affected skin area.

Administration is generally as-needed (PRN), guided by the temporary need for relief rather than a fixed treatment duration.


Administration Context and Specific Populations

For oral use, the medicine is typically timed to be taken after meals and at bedtime. The physical form dictates specific preparation requirements: chewable tablets must be chewed thoroughly before swallowing, and liquid suspensions must be measured precisely using the calibrated dropper or measuring spoon provided.

Dosing modifications are mandated for pediatric patients. For the antifoaming use, children 2–12 years are administered 40 mg per dose (max 480 mg/day), while infants under 2 years are administered 20 mg per dose (max 240 mg/day).

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Цеолат


Evidence for use in Reducing Toxin Exposure and Detoxification

Research exploring the role of Цеолат has largely centered on how it interacts with various substances. Studies, including laboratory research (in vitro) and some early human studies, have examined Цеолат for its binding properties and whether this influences the absorption of various toxins, heavy metals, and harmful substances within the digestive tract. These studies often monitored outcomes related to systemic or functional imbalance by measuring the presence of certain compounds during the study period.

The findings indicate patterns related to the binding capacity of Цеолат in controlled laboratory settings. In human research, some studies observed how symptoms evolved in the populations studied and monitored changes related to internal toxin levels during the study period. However, the extent to which these measured changes in the body lead to noticeable differences in outcomes reflecting daily functioning or activity level in the general population is still uncertain.

Evidence for use in Supporting Digestive Health

Цеолат was evaluated in studies focused on outcomes related to supporting the digestive system. These trials, often applied in studies examining patient-reported experiences and outcomes related to physical discomfort, explored Цеолат’s role in outcomes related to gut barrier function, the gut microbiome balance, and its use in populations reporting perceived discomfort. This research often looked at patient-reported outcomes describing perceived discomfort in conditions characterized by fluctuating or episodic manifestations.

In studies where participants had conditions involving periods of heightened symptoms, the findings describe patterns observed in the studies where use of Цеолат was associated with changes in patient-reported outcomes describing perceived discomfort over defined time intervals. However, data are still emerging, and comparative evidence is lacking to fully understand the range of its activity for supporting digestive health.


Long-term Studies and Follow-up

Research focusing on the long-term observation of Цеолат is an area where evidence is limited. Studies monitored responses over relatively defined time intervals, meaning that information regarding the durability of any observed effects or the complete profile of continuous, extended-duration use is not fully clear. There is limited information for long-term outcomes that capture how observed patterns evolved over many years.

What is still uncertain about Цеолат

The body of research on Цеолат highlights several areas where more study is needed. The main evidence gaps include a need for more research to clarify the specific conditions under which it has been studied and more data on its activity across all conditions marked by functional limitations. Research highlights what is known — and what is still uncertain, and future studies will need to address these gaps before a complete picture of Цеолат’s role in health can be fully understood.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Цеолат (FAQ)

Q: Is Цеолат considered a strong medicine?

A: Official documents describe Цеолат as a pharmacologically inert substance that works via a physical mechanism, such as surface tension reduction or barrier formation. This classification indicates that the medicine does not interact with the body's systems like a traditional, systemically absorbed drug.

Therefore, its effects are purely local rather than affecting the entire body.


Q: How is Цеолат different from other drugs for similar issues?

A: Цеолат (Dimethicone) is distinct from many other medications because it acts via a physical mechanism and is not systemically absorbed into the bloodstream. It does not rely on biological targets like receptors or enzymes, unlike most absorbed drugs.

Official information also explicitly contrasts it with its close derivative, Simethicone, a specialized antifoam blend.


Q: Why do some people say Цеолат is a natural alternative?

A: Official documents specify that Цеолат (Dimethicone) is a synthetic, silicone-based polymer. It is chemically defined as Polydimethylsiloxane, differentiating its origin from compounds derived from natural sources.

Its regulatory classification identifies it as a synthetic, silicone-based polymer.


Q: Can Цеолат be taken long-term?

A: Official guidance indicates that administration is generally as-needed (PRN), not for a fixed treatment duration. The research evidence on extended durability of effects from continuous, long-term systemic use is described as limited.

While the active ingredient is generally used safely in topical products due to its non-absorbed nature, the official approach is based on temporary need.


Q: What should I expect in the first few days of taking Цеолат?

A: The medicine works via a physical, local mechanism in the gastrointestinal tract or on the skin. Expectations are generally aligned with the onset of relief from the symptoms being addressed (e.g., gas, bloating, or irritation).

Because it is not systemically absorbed, it does not typically produce a generalized physical sensation throughout the body.


Q: How quickly does Цеолат start working, based on research?

A: The physical mechanism of Цеолат—breaking down gas bubbles or forming a protective barrier—suggests that its localized effect may occur rapidly at the site of application. While regulatory documents do not specify an exact time-to-onset in minutes, the non-systemic nature suggests its localized effect may occur rapidly.


Q: Does Цеолат make you feel tired or sleepy?

A: Adverse reaction profiles listed in official regulatory documents do not include tiredness, drowsiness, or fatigue. This absence is consistent with the drug's nature as a non-systemic compound that is not absorbed into the bloodstream or metabolized by the body.


Q: Will Цеолат interact with my vitamins or supplements?

A: Official regulatory documents confirm no systemic drug interactions because the medicine is not absorbed. The established interaction profile focuses on the potential for physical adsorption within the gastrointestinal tract.

This physical effect may alter the concentration of any co-administered oral products, including certain vitamins and mineral supplements, if taken at the exact same time.


Q: Is it safe to take Цеолат with common pain relievers like ibuprofen?

A: Official documentation indicates there is no systemic interaction risk with other medicines because Цеолат is minimally absorbed. The primary focus of interaction concern is the potential for physical adsorption in the gut.

This means that taking Цеолат simultaneously with any other oral medicine, including common pain relievers, may potentially alter the absorption concentration of the co-administered drug.


Q: Are there any clinical trials published about the long-term effects of Цеолат?

A: Research focusing on long-term observation of Цеолат is an area where official evidence is limited. Studies have generally monitored responses over defined time intervals.

This means that information on the complete profile of continuous, extended-duration use or the durability of observed effects is not fully clear from the existing body of trials.


Q: Is Цеолат used outside of its primary approved purpose?

A: Official medical and regulatory documents only contain information and guidance pertaining to the specific conditions and uses for which the medicine has been formally approved and labeled.

Guidance and safety information provided by regulators focus on these approved indications.


Q: Does Цеолат contain any common allergens?

A: Regulatory information contraindicates use if an individual has a known allergy to the active substance (Dimethicone) or any excipients (inactive ingredients) in the specific formulation.

While the active ingredient is generally not listed as a common allergen, individuals with specific sensitivities should review the full ingredient list.


Q: Is Цеолат available over the counter, or is it prescription only?

A: The active ingredient, Dimethicone, is recognized by the FDA as suitable for use in Over-the-Counter (OTC) products, specifically for its purpose as a skin protectant.

Many formulations, including those for oral antifoaming use, are also categorized as OTC drugs.


Q: If I miss a dose of Цеолат, what do official instructions say I should do?

A: Since the medicine is often used on an as-needed (PRN) basis, official instructions relate the approach for a missed dose to whether the product is being used on an as-needed or scheduled basis.

Guidance for regular scheduling suggests taking the missed dose when remembered or skipping it if it is near the next scheduled dose. Official guidance advises against taking a double dose to compensate for a forgotten one.


Q: Can I stop taking Цеолат suddenly?

A: Administration is generally as-needed (PRN), not a fixed-duration regimen, and the drug is not systemically absorbed. This means that the product is not associated with dependency.

Official documents do not typically contain specific instructions for stopping use, suggesting it can be discontinued when the temporary need for relief has passed.


Q: What is the official purpose of the warnings section for Цеолат?

A: The purpose of the warnings and safety information in official documents is to notify patients and prescribers of the most important safety details. This includes absolute prohibitions (contraindications) for use and the potential for serious, though rare, adverse reactions.


Q: Is Цеолат known to cause weight gain or loss?

A: Weight gain or loss is not listed in the adverse reaction profile of Цеолат found in official regulatory documents. This is consistent with the medicine's non-systemic nature, as it is not absorbed or metabolized by the body in a way that typically influences metabolism or weight.


Q: Does Цеолат affect blood pressure?

A: Official regulatory documents and the adverse reaction profile do not list changes in blood pressure or heart rate. This aligns with the medicine's defining characteristic of minimal to absent systemic absorption.

Because the drug does not enter the bloodstream substantially, it is not expected to have systemic cardiovascular effects.


Q: Why is hydration sometimes mentioned when discussing Цеолат?

A: For topical use, Цеолат's physical mechanism involves creating an inert, occlusive barrier on the skin's surface. This barrier physically impedes water loss (transepidermal water loss), which is the basis for its action in maintaining skin hydration and integrity.


Q: What should I do if I think I'm having a rare side effect?

A: Official regulatory bodies indicate that any suspected severe or rare adverse reaction should be reported to a healthcare provider.

The FDA also provides a voluntary reporting system for consumers and professionals via the MedWatch program for documenting unexpected reactions.


Q: How is Цеолат usually packaged?

A: Packaging varies based on the formulation, which includes liquid suspensions and chewable tablets for oral use, and various topical forms like creams or lotions.

Official labels show products are generally supplied in sealed bottles, tubes, or cartons.


Q: Are there different strengths of Цеолат available?

A: Yes, the medicine is available in various forms and different strengths for both topical and oral administration. Official documents detail varying doses for different populations (e.g., 20 mg, 40 mg, up to 125 mg) and different concentration percentages for topical preparations.


Q: What happens if Цеолат is used for longer than recommended?

A: Administration is generally as-needed (PRN), with a maximum daily limit. Regulatory documents warn that rare intestinal obstruction or bezoar formation is documented with high molecular weight silicone polymers.

For topical use, regulatory information notes that extended use may cause skin irritation.


Q: Is the effect of Цеолат permanent or only while using it?

A: The effect is considered temporary because the mechanism of action is physical and non-systemic. The effect is exerted locally at the site of application (gas bubbles or skin surface).

Relief ceases as the body naturally removes the compound via expulsion or surface turnover.


Q: Is it normal to feel no difference immediately after starting Цеолат?

A: The medicine is non-systemic and does not cause a generalized, whole-body sensation upon use. Since the effects are localized and related to the purpose of use, it is normal not to feel a systemic difference immediately.

The desired relief is typically local and temporary.


Q: Does Цеолат have any withdrawal symptoms reported in clinical literature?

A: The adverse reaction profile and official regulatory documentation for this medicine do not list any reported withdrawal symptoms. This is consistent with its non-systemic, physical mechanism of action, which is not associated with dependency.


Q: Is Цеолат commonly used in other countries?

A: The active ingredient in Цеолат, Dimethicone, is a widely used compound in medical products and is formally approved and utilized in various combinations and formulations across numerous international regulatory jurisdictions.

Its safety profile makes it a common ingredient globally.


Q: How does the official document describe the duration of Цеолат's effects?

A: Official instructions specify that the medicine may be administered up to four times a day and is generally as-needed (PRN), which suggests a temporary duration of effect.

The frequency of re-dosing is dictated by the persistence of symptoms being treated.


Q: Is there a generic version of Цеолат?

A: As a single-ingredient product whose active substance is the widely-used compound Dimethicone, it is available in many generic and store-brand formulations.

These formulations are generally recognized by regulatory bodies as suitable for Over-the-Counter (OTC) use.

Advertisements

How should Цеолат be stored and disposed of?

The storage and disposal of Цеолат (Dimethicone) must adhere strictly to regulatory guidelines to maintain its stability and prevent accidental exposure.

Storage Requirements

Цеолат must be stored at controlled room temperature, typically between 20 C to 25 C. The container should be kept tightly closed to protect the product from air and moisture. It is required to keep the medicine away from direct sunlight and excess heat, meaning it should not be stored in places like a bathroom. Mandatory child-safety precautions require keeping Цеолат out of the sight and reach of children.

Disposal Instructions

Unused or expired Цеолат must be properly discarded. The official preference for disposal is using a drug take-back program. If this option is unavailable, the product should be mixed with an undesirable substance (e.g., dirt) in a sealed container and placed in the household trash. Do not flush Цеолат down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Цеолат found in:

A-Z Index: